Clinical Trial Update: Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) [Phase 3]

View source ↗

Summary

Phase 3 trial DEMAND evaluating the combination of delapril and manidipine for nephroprotection in diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Delapril (delapril)
• Manidipine (manidipine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED